NO980906D0 - Nye, antikonvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som i 4-stilling inneholder en disubstituert aminrest og en fremgangsmåte for deres fremstilling - Google Patents

Nye, antikonvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som i 4-stilling inneholder en disubstituert aminrest og en fremgangsmåte for deres fremstilling

Info

Publication number
NO980906D0
NO980906D0 NO980906A NO980906A NO980906D0 NO 980906 D0 NO980906 D0 NO 980906D0 NO 980906 A NO980906 A NO 980906A NO 980906 A NO980906 A NO 980906A NO 980906 D0 NO980906 D0 NO 980906D0
Authority
NO
Norway
Prior art keywords
imidazolin
anticonvulsant
alk
ones
acting
Prior art date
Application number
NO980906A
Other languages
English (en)
Other versions
NO313829B1 (no
NO980906L (no
Inventor
Hans-Joachim Lankau
Manfred Menzer
Klaus Unverferth
Karl Gewald
Harry Schaefer
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO980906(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of NO980906L publication Critical patent/NO980906L/no
Publication of NO980906D0 publication Critical patent/NO980906D0/no
Publication of NO313829B1 publication Critical patent/NO313829B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19980906A 1995-09-05 1998-03-02 Antikonvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner og deres anvendelse for fremstilling av forbindelser til behandlingav sykdommer i sentralnervesystemet NO313829B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
NO980906L NO980906L (no) 1998-03-02
NO980906D0 true NO980906D0 (no) 1998-03-02
NO313829B1 NO313829B1 (no) 2002-12-09

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980906A NO313829B1 (no) 1995-09-05 1998-03-02 Antikonvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner og deres anvendelse for fremstilling av forbindelser til behandlingav sykdommer i sentralnervesystemet

Country Status (32)

Country Link
EP (1) EP0863880B1 (no)
JP (1) JP4030578B2 (no)
CN (1) CN1103762C (no)
AR (1) AR003502A1 (no)
AT (1) ATE254606T1 (no)
AU (1) AU700602B2 (no)
BG (1) BG63917B1 (no)
BR (1) BR9610359A (no)
CA (1) CA2184871C (no)
CZ (1) CZ291839B6 (no)
DE (2) DE19532668A1 (no)
DK (1) DK0863880T3 (no)
EA (1) EA000535B1 (no)
EE (1) EE03562B1 (no)
ES (1) ES2208758T3 (no)
FR (1) FR13C0049I2 (no)
GE (1) GEP20022652B (no)
HK (1) HK1015776A1 (no)
HU (1) HU225956B1 (no)
IL (1) IL123333A (no)
LT (1) LT4482B (no)
LU (1) LU92263I2 (no)
NO (1) NO313829B1 (no)
NZ (1) NZ315624A (no)
PL (1) PL188287B1 (no)
PT (1) PT863880E (no)
SK (1) SK284868B6 (no)
TR (1) TR199800476T1 (no)
TW (1) TW422838B (no)
UA (1) UA46790C2 (no)
WO (1) WO1997009314A1 (no)
ZA (1) ZA967014B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
JP2009513539A (ja) * 2003-07-11 2009-04-02 ベーリンガー・インゲルハイム・フエトメデイカ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング ベンゾジアゼピンレセプターのアルファ３サブユニットに対する選択性を有する化合物を用いて中枢神経系障害を治療または予防する方法
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
MX2014001556A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Composicion farmaceutica de sabor enmascarado.
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
WO1997009314A1 (de) 1997-03-13
IL123333A (en) 2001-10-31
SK284868B6 (sk) 2006-01-05
PT863880E (pt) 2004-04-30
LT4482B (lt) 1999-03-25
DE19532668A1 (de) 1997-03-06
JP4030578B2 (ja) 2008-01-09
AU6737596A (en) 1997-03-27
HU225956B1 (en) 2008-01-28
EP0863880A1 (de) 1998-09-16
EE03562B1 (et) 2001-12-17
NO313829B1 (no) 2002-12-09
CA2184871A1 (en) 1997-03-06
EA000535B1 (ru) 1999-10-28
PL188287B1 (pl) 2005-01-31
BG63917B1 (bg) 2003-06-30
CN1103762C (zh) 2003-03-26
CZ66198A3 (cs) 1998-07-15
TW422838B (en) 2001-02-21
JPH11512101A (ja) 1999-10-19
CZ291839B6 (cs) 2003-06-18
EE9800063A (et) 1998-08-17
DE59610827D1 (de) 2003-12-24
CN1200728A (zh) 1998-12-02
ES2208758T3 (es) 2004-06-16
TR199800476T1 (xx) 1998-06-22
UA46790C2 (uk) 2002-06-17
EA199800271A1 (ru) 1998-10-29
AU700602B2 (en) 1999-01-07
AR003502A1 (es) 1998-08-05
HUP9802941A3 (en) 1999-10-28
IL123333A0 (en) 1998-09-24
DK0863880T3 (da) 2004-03-22
HK1015776A1 (en) 1999-10-22
ATE254606T1 (de) 2003-12-15
LT98047A (en) 1998-10-26
BR9610359A (pt) 1999-07-06
GEP20022652B (en) 2002-03-25
NO980906L (no) 1998-03-02
MX9801742A (es) 1998-08-30
HUP9802941A2 (hu) 1999-09-28
CA2184871C (en) 2001-08-21
EP0863880B1 (de) 2003-11-19
LU92263I2 (fr) 2013-10-07
SK21698A3 (en) 1998-10-07
FR13C0049I1 (no) 2013-09-27
PL325413A1 (en) 1998-07-20
BG102287A (en) 1998-09-30
ZA967014B (en) 1997-08-18
FR13C0049I2 (fr) 2014-03-28
NZ315624A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
DK0855999T3 (da) 1-(1,2-disubstituerede piperidinyl)-4-substituerede piperidinderivater som tachykininreceptorantagonister
NO981534D0 (no) 1-(1,2-disubstituert piperidinyl)-4-substituerte piperazinderivater
NO20005454D0 (no) Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmÕte for fremstilling derav
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
TR199600930A2 (tr) Kristal yapida (R)-(-)-2-{N-£4-(1,1-dioksido-3-okzo-2, 3-dihidrobenzizotiazol-2-il)-butil|- aminometil}-kroman hidroklorür.
DE69827557D1 (de) Vorrichtung zum Ausrichten von Teilen.
NO964654D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DE69919632D1 (de) Fehlertoleranz durch N-modulare Softwareredundanz unter Verwendung von indirekter Instrumentierung
DK0858440T3 (da) Fremgangsmåde til fremstilling af 1,1,1,3,3-pentafluorpropan
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO985671L (no) Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte
DK0843679T3 (da) 1-(1,2-disubstitueret piperidinyl)-4-(kondenseret midazol)-piperidinderivater
DK1045856T3 (da) Nye aromatiske amider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
AR004368A1 (es) Compuestos de piperidina -1,-4 sustituida, procedimientos para prepararlos y un procedimiento para preparar 1-bencil-4-((5,6-dimetoxi-1-indanon)-2-il)metilpiperidina mediante dichos compuestos.
NO980906D0 (no) Nye, antikonvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som i 4-stilling inneholder en disubstituert aminrest og en fremgangsmåte for deres fremstilling
NO951928D0 (no) Sementeringssystem for forlengingsrör, samt fremgangsmåte
NO982708D0 (no) Nye fenylamidinderivater, fremgangsmÕte for fremstilling derav og deres anvendelse som legemidler
NO953321D0 (no) 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler
NO20002588L (no) Bifenylamidinderivater
DK199901582A (da) Pladebukkemaskine, henholdsvis værktøjsholderdel og bukkeværktøj til samme
DK0906326T3 (da) Nye aromatiske derivater substitueret med en ribose, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0946579T3 (da) Nye forbindelser afledt af erythromcin, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
EP1620857A4 (en) MEMORY REDUNDANCY ACTIVATED DURING THE TEST
ITVI910109A1 (it) Regolatore di pressione per gas.
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel

Legal Events

Date Code Title Description
MK1K Patent expired